Article
Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease
11 Sept 2023
Abstract excerpt
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease. Metabolism-related genes significantly influence the onset and progression of the disease. Hence, it is necessary to screen metabolism-related biomarkers for the diagnosis and treatment of NAFLD patients. METHODS: GSE48452, GSE63067, and GSE89632 datasets including nonalcoholic steatohepatitis (NASH) and healthy controls (HC)...
Topics
Join the communities discussing this publication.
